At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...
A new point-of-care prediction tool that uses clinical and ultrasonography findings has good accuracy for identifying giant cell arteritis among patients seen in fast-track clinics. Investigators ...
Please provide your email address to receive an email when new articles are posted on . Upadacitinib bested placebo for achieving remission at 52 weeks in GCA, a new indication for the drug. The ...
Findings showed 46% of patients who received upadacitinib 15mg achieved sustained remission at week 52 compared with 29% of patients who received placebo. Patients with giant cell arteritis (GCA) who ...
Explore causes, symptoms and diagnosis of Giant Cell Arteritis and Temporal Arteritis including headache, vision loss and jaw ...
While not used to guide treatment, ESR and CRP typically normalize within two to four weeks after initiating therapy. 2,4 Minor increases in ESR can occur during the prednisone taper, but this does ...
Please provide your email address to receive an email when new articles are posted on . Binocular diplopia was not an exceptional feature at GCA diagnosis. Diplopia resolution tends to be faster in ...
Recent advances in the study of inflammatory vasculitides have underscored the complexity of both giant cell arteritis (GCA) and Takayasu arteritis (TAK). Research has increasingly revealed the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Senescence ...
DelveInsight'sā€œ Giant-Cell Arteritis Pipeline Insight 2025 ā€ report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in the Giant-Cell Arteritis pipeline landscape. It covers ...
A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of ...